Celldex Therapeutics, Inc. - COM NEW (CLDX)

Q1 2022 13F Holders as of 3/31/2022

Type / Class
Equity / COM NEW
Number of holders
158
Total Shares
49.6M
Shares change
+3.34M
Total reported value, excl. options
$1.69B
Value change
+$106M
Put/Call ratio
0.64
Number of buys
80
Number of sells
-75
Price
$34.06
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.